filmov
tv
Ballooning change is steatohepatitis of liver. NASH
Показать описание
Non alcoholic steatohepatitis (NASH)
0:03:07
Ballooning change is steatohepatitis of liver. NASH
1:02:08
The Fatty Liver: pathology of NASH with an emphasis on fibrosis - Dr. Saxena (IU) #LIVERPATH
0:31:32
Emerging Therapies in NASH
0:00:32
ballooning degeneration
0:27:04
Novel Therapeutic Strategies to Improve Nonalcoholic Steatohepatitis Outcomes
1:03:15
A Proteomics Signature of NASH
1:00:57
Nonalcoholic Fatty Liver Disease 2019
0:58:27
Clinical Update on the Management of Fatty Liver Disease in T2DM Patients
0:48:30
Clinical overview of NAFL/NASH
0:41:05
EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?
0:07:25
Necrosis, apoptosis and regeneration - liver pathology
0:54:29
Non-alcoholic Fatty Liver Disease
0:27:51
CK18 as a Biomarker in NASH Clinical Trials
0:30:29
A Rapid NASH Model
0:19:40
Medical Management of Fatty Liver Disease
0:58:04
Fatty Liver Disease Webinar - July 2021
0:08:56
The Liver, Part 2: The pathophysiology of non-alcoholic fatty liver disease
0:03:37
Histological features of chronic cholestasis
1:58:45
Conference about NASH disease in New York City - International NASH Day 2019
0:14:11
Hepatic Steatosis Part 1: Pathophysiology
1:19:57
Ask the Experts: NASH and Your Diet
0:31:26
New Therapies for NASH/NAFLD | Thomas Berg, MD
1:03:10
2019 MSK Alumni Conference - Linda Ferrell MD
1:33:56
Fatty liver disease in Latin America—an emerging public health threat
Комментарии